BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 21590687)

  • 21. Phase I study of perifosine monotherapy in patients with recurrent or refractory neuroblastoma.
    Matsumoto K; Shichino H; Kawamoto H; Kosaka Y; Chin M; Kato K; Mugishima H
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28521076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathway.
    Elrod HA; Lin YD; Yue P; Wang X; Lonial S; Khuri FR; Sun SY
    Mol Cancer Ther; 2007 Jul; 6(7):2029-38. PubMed ID: 17604333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The alkylphospholipid perifosine induces apoptosis and p21-mediated cell cycle arrest in medulloblastoma.
    Kumar A; Fillmore HL; Kadian R; Broaddus WC; Tye GW; Van Meter TE
    Mol Cancer Res; 2009 Nov; 7(11):1813-21. PubMed ID: 19887560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cells.
    de la Peña L; Burgan WE; Carter DJ; Hollingshead MG; Satyamitra M; Camphausen K; Tofilon PJ
    Mol Cancer Ther; 2006 Jun; 5(6):1504-10. PubMed ID: 16818509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma.
    Kushner BH; Cheung NV; Modak S; Becher OJ; Basu EM; Roberts SS; Kramer K; Dunkel IJ
    Int J Cancer; 2017 Jan; 140(2):480-484. PubMed ID: 27649927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Brain-derived neurotrophic factor protects cementoblasts from serum starvation-induced cell death.
    Kajiya M; Shiba H; Fujita T; Takeda K; Uchida Y; Kawaguchi H; Kitagawa M; Takata T; Kurihara H
    J Cell Physiol; 2009 Dec; 221(3):696-706. PubMed ID: 19711359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor Perifosine in acute myelogenous leukemia cells.
    Tazzari PL; Tabellini G; Ricci F; Papa V; Bortul R; Chiarini F; Evangelisti C; Martinelli G; Bontadini A; Cocco L; McCubrey JA; Martelli AM
    Cancer Res; 2008 Nov; 68(22):9394-403. PubMed ID: 19010914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paracrine and autocrine functions of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in brain-derived endothelial cells.
    Kim H; Li Q; Hempstead BL; Madri JA
    J Biol Chem; 2004 Aug; 279(32):33538-46. PubMed ID: 15169782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual inhibition of akt/mammalian target of rapamycin pathway by nanoparticle albumin-bound-rapamycin and perifosine induces antitumor activity in multiple myeloma.
    Cirstea D; Hideshima T; Rodig S; Santo L; Pozzi S; Vallet S; Ikeda H; Perrone G; Gorgun G; Patel K; Desai N; Sportelli P; Kapoor S; Vali S; Mukherjee S; Munshi NC; Anderson KC; Raje N
    Mol Cancer Ther; 2010 Apr; 9(4):963-75. PubMed ID: 20371718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Perifosine, an AKT inhibitor, modulates ovarian cancer cell line sensitivity to cisplatin-induced growth arrest.
    Al Sawah E; Chen X; Marchion DC; Xiong Y; Ramirez IJ; Abbasi F; Bou Zgheib N; Chon HS; Wenham RM; Apte SM; Judson PL; Lancaster JM
    Gynecol Oncol; 2013 Oct; 131(1):207-12. PubMed ID: 23877012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of CEP-751 (KT-6587) on neuroblastoma xenografts expressing TrkB.
    Evans AE; Kisselbach KD; Liu X; Eggert A; Ikegaki N; Camoratto AM; Dionne C; Brodeur GM
    Med Pediatr Oncol; 2001 Jan; 36(1):181-4. PubMed ID: 11464878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylation.
    Engel JB; Honig A; Schönhals T; Weidler C; Häusler S; Krockenberger M; Grunewald TG; Dombrowski Y; Rieger L; Dietl J; Wischhusen J
    Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):64-9. PubMed ID: 18687514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of ATXN3 Enhances the Sensitivity to AKT Inhibitors (Perifosine or MK-2206), but Decreases the Sensitivity to Chemotherapeutic Drugs (Etoposide or Cisplatin) in Neuroblastoma Cells.
    Gong B; Zhang J; Hua Z; Liu Z; Thiele CJ; Li Z
    Front Oncol; 2021; 11():686898. PubMed ID: 34322387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain-derived neurotrophic factor protects neuroblastoma cells from vinblastine toxicity.
    Scala S; Wosikowski K; Giannakakou P; Valle P; Biedler JL; Spengler BA; Lucarelli E; Bates SE; Thiele CJ
    Cancer Res; 1996 Aug; 56(16):3737-42. PubMed ID: 8706017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical Efficacy for AKT Targeting in Clear Cell Carcinoma of the Ovary.
    Sasano T; Mabuchi S; Kuroda H; Kawano M; Matsumoto Y; Takahashi R; Hisamatsu T; Sawada K; Hashimoto K; Isobe A; Testa JR; Kimura T
    Mol Cancer Res; 2015 Apr; 13(4):795-806. PubMed ID: 25519148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p38MAPK inhibition: a new combined approach to reduce neuroblastoma resistance under etoposide treatment.
    Marengo B; De Ciucis CG; Ricciarelli R; Furfaro AL; Colla R; Canepa E; Traverso N; Marinari UM; Pronzato MA; Domenicotti C
    Cell Death Dis; 2013 Apr; 4(4):e589. PubMed ID: 23579276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of antitumor activity of the anti-EGF receptor monoclonal antibody cetuximab/C225 by perifosine in PTEN-deficient cancer cells.
    Li X; Luwor R; Lu Y; Liang K; Fan Z
    Oncogene; 2006 Jan; 25(4):525-35. PubMed ID: 16170346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perifosine enhances the potential antitumor effect of 5-fluorourasil and oxaliplatin in colon cancer cells harboring the PIK3CA mutation.
    Morii Y; Tsubaki M; Takeda T; Otubo R; Seki S; Yamatomo Y; Imano M; Satou T; Shimomura K; Nishida S
    Eur J Pharmacol; 2021 May; 898():173957. PubMed ID: 33662352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
    Groh T; Hrabeta J; Poljakova J; Eckschlager T; Stiborova M
    Neuro Endocrinol Lett; 2012; 33 Suppl 3():16-24. PubMed ID: 23353839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation.
    Kondapaka SB; Singh SS; Dasmahapatra GP; Sausville EA; Roy KK
    Mol Cancer Ther; 2003 Nov; 2(11):1093-103. PubMed ID: 14617782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.